- Home
- PULM vs IPA Comparison
PULM vs IPA Comparison
Compare PULM & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- IPA
- Stock Information
- Founded
- PULM 2003
- IPA 1983
- Country
- PULM United States
- IPA Canada
- Employees
- PULM 22
- IPA N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- PULM Health Care
- IPA Health Care
- Exchange
- PULM Nasdaq
- IPA Nasdaq
- Market Cap
- PULM 21.9M
- IPA 18.9M
- IPO Year
- PULM N/A
- IPA 2017
- Fundamental
- Price
- PULM $5.80
- IPA $0.39
- Analyst Decision
- PULM
- IPA Strong Buy
- Analyst Count
- PULM 0
- IPA 2
- Target Price
- PULM N/A
- IPA $5.00
- AVG Volume (30 Days)
- PULM 131.2K
- IPA 287.2K
- Earning Date
- PULM 11-08-2024
- IPA 12-10-2024
- Dividend Yield
- PULM N/A
- IPA N/A
- EPS Growth
- PULM N/A
- IPA N/A
- EPS
- PULM N/A
- IPA N/A
- Revenue
- PULM $10,005,000.00
- IPA $17,272,336.00
- Revenue This Year
- PULM N/A
- IPA $1.88
- Revenue Next Year
- PULM $1.00
- IPA $9.90
- P/E Ratio
- PULM N/A
- IPA N/A
- Revenue Growth
- PULM 47.05
- IPA 6.36
- 52 Week Low
- PULM $1.55
- IPA $0.33
- 52 Week High
- PULM $8.44
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- PULM 57.17
- IPA 46.02
- Support Level
- PULM $5.80
- IPA $0.40
- Resistance Level
- PULM $6.57
- IPA $0.45
- Average True Range (ATR)
- PULM 0.43
- IPA 0.04
- MACD
- PULM -0.14
- IPA 0.01
- Stochastic Oscillator
- PULM 36.69
- IPA 33.92
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.